Healthcare Realty Trust (HR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
29 Dec, 2025Executive summary
Leadership changes included a new interim CEO, new independent directors, and a new CFO, with a board refresh adding four new directors and a search committee established for a permanent CEO.
Reported net loss attributable to common stockholders of $(106.8) million for Q4 2024 and $(654.5) million for the year, driven by impairments and restructuring costs.
Normalized FFO per share was $0.40 for Q4 2024, up 2.5% year-over-year, and $1.56 for the year, at the high end of guidance.
Achieved record leasing activity with 686,000 sq ft of new leases signed in Q4 and 1,534,000 sq ft commenced, marking the sixth consecutive quarter above 400,000 sq ft.
Strategic priorities for 2025 emphasize operational growth, portfolio refinement, and significant debt reduction.
Financial highlights
Normalized FFO per share for Q4 2024 was $0.40, and $1.56 for the year, both at the high end of guidance.
Same-store Cash NOI grew 3.1% in Q4 and 2.9% for the year; excluding bankrupt tenants, growth was 3.6% and 3.1%, respectively.
Multi-tenant occupancy ended the year at 86.3%, with leased percentage at 88.3%.
$1.3 billion in capital was raised, including $500 million from non-core asset sales and $522 million in joint venture and asset sale transactions in Q4.
Net debt to adjusted EBITDA improved to 6.4x at year-end, down from 6.7x in Q3.
Outlook and guidance
2025 normalized FFO per share guidance is $1.48–$1.60; same-store NOI growth expected between 3.00% and 3.75%, excluding Prospect Medical and Steward Health.
$400–$500 million in non-core asset sales planned for 2025, with proceeds prioritized for leasing capital and debt repayment.
Leverage targeted to decline to 6.0–6.25x by year-end 2025.
Dividend coverage expected by Q4 2025 or early 2026, depending on leasing activity.
Guidance reflects assumptions on rental rates, occupancy, interest rates, and expenses, and excludes impacts from gains/losses on dispositions or impairments.
Latest events from Healthcare Realty Trust
- Strong leasing, $1.2B asset sales, and improved leverage drive positive 2025 and 2026 outlook.HR
Q4 202513 Feb 2026 - Q2 net loss on impairments, but strong leasing, asset sales, and FFO guidance affirmed.HR
Q2 20242 Feb 2026 - Normalized FFO per share rose 1.2% as leasing, asset sales, and share buybacks drove activity.HR
Q3 202417 Jan 2026 - Normalized FFO per share was $0.39 in Q1 2025, with improved net loss and strong leasing.HR
Q1 202527 Dec 2025 - Board recommends approval of all proposals, with strong focus on pay-for-performance and ESG.HR
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.HR
Proxy Filing1 Dec 2025 - Q2 2025 saw strong FFO, higher guidance, a dividend cut, and major asset sales.HR
Q2 202516 Nov 2025 - Q3 2025 saw 5% FFO growth, strong leasing, asset sales, and improved guidance despite a net loss.HR
Q3 20252 Nov 2025